NCT00396279 2022-11-08
Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone
Amgen
Phase 2 Completed
Amgen
Dana-Farber Cancer Institute
Loyola University
Children's Hospital Los Angeles
Loyola University
Stanford University
Wake Forest University Health Sciences
University of Kansas Medical Center
Stanford University
Georgetown University